Showing 341-350 of 551 results for "".
Evolution in Dermatology/Industry Partnerships
https://practicaldermatology.com/topics/practice-management/evolution-in-dermatologyindustry-partnerships/23295/The COVID-19 crisis is changing the dermatology industry. What does it mean?Digital Innovation to the Rescue: The Future of Electronic Prior Authorization in Dermatology
https://practicaldermatology.com/topics/practice-management/digital-innovation-to-the-rescue-the-future-of-electronic-prior-authorization-in-dermatology/20467/Adopting new technology to reduce paperwork, costs, and burnout as well as improve patient care.New Products and Pharmacological Developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacological-developments/20429/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20634/The Dermatology Industry: A Status Report
https://practicaldermatology.com/topics/psoriasis/the-dermatology-industry-a-status-report/21072/The two companies that stole the spotlight in 2014 continue to drive industry news in the dermatology space.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-33/23690/Getting to the Root of ACD
https://practicaldermatology.com/topics/atopic-dermatitis/getting-to-the-root-of-acd/20356/A practical approach to dermatitis in young and old.Laser Therapy for Atrophic Acne Scars: A Case and Evidence-based Updates
https://practicaldermatology.com/topics/acne-rosacea/laser-therapy-for-atrophic-acne-scars-a-case-and-evidence-based-updates/23737/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20409/An Overview of Topical Therapies for Managing Pediatric AD
https://practicaldermatology.com/topics/atopic-dermatitis/an-overview-of-topical-ththerapies-for-managing-pediatric-ad/54375/Moisturization is foundational in AD management; no specific formulation has demonstrated superiority, and excessive bathing may worsen disease via increased transepidermal water loss. Topical corticosteroids and calcineurin inhibitors remain first-line due to strong efficacy data, cost-effectivene